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Abstract 
 
Background: Information concerning tracheostomy after surgery for congenital heart 
disease has come primarily from single center reports. We aimed to describe the 
epidemiology and outcomes associated with postoperative tracheostomy in a multi-
institutional registry. 
Methods: The Society of Thoracic Surgeons Congenital Heart Database (2000-2014) 
was queried for all index operations with the complication “postoperative tracheostomy” 
or “respiratory failure, requiring tracheostomy.” Patients with preoperative tracheostomy 
or less than 2.5 kg undergoing isolated closure of patent ductus arteriosus were 
excluded. Trends in tracheostomy incidence over time from 1/2000 to 6/2014 were 
analyzed using a Cochran-Armitage test. Patient characteristics associated with 
operative mortality were analyzed for 1/2010 to 6/2014, which includes deaths occurring 
up to 6 months after transfer to chronic care facilities. 
Results:  From 2000-2014, tracheostomy incidence following surgery for congenital 
heart disease increased from 0.11% in 2000 to a high of 0.76% in 2012, p<0.0001.  
From 2010-2014, 648 patients underwent tracheostomy. Median age at surgery was 2.5 
months (25th, 75th percentile: 0.4-7).  Prematurity (n=165, 26%), genetic abnormalities 
(n=298, 46%), and preoperative mechanical ventilation (n=275, 43%) were common. 
Postoperative complications were also common including cardiac arrest (n=131, 20%), 
extracorporeal support (n=87, 13%), phrenic or laryngeal nerve injury (n=114, 18%), and 
neurological deficit (n=51, 8%). Operative mortality was 25% (n=153).   
Conclusions: Tracheostomy as a complication of surgery for congenital heart disease 
remains rare but has been increasingly utilized over the past 15 years.  This trend and 
the considerable mortality risk among patients requiring postoperative tracheostomy 
support the need for further research in this complex population. 
Word Count:  250 
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Introduction 
As the field of pediatric cardiovascular surgery has evolved, surgical repair or palliation 
of patients with complex underlying cardiac lesions who often have co-existent non-
cardiac co-morbidities has become commonplace at most centers.  Many of these 
patients have prolonged postoperative courses, including prolonged need for mechanical 
ventilation.   In some cases, liberation from mechanical ventilation is not possible and 
tracheostomy is considered.  Several institutions have reported their experiences with 
pediatric patients requiring tracheostomy following cardiac surgery.[1-5] The incidence of 
tracheostomy after pediatric cardiac surgery in these reviews ranged from 0.2-2.7%.  In-
hospital mortality was much more variable, ranging from 0-40% [1-5].  In the two most 
contemporary reports (published in 2011 and 2014), in-hospital mortality rates were 22% 
and 11%.[4,5]  In a study by Berry and colleagues reporting data from a large multi-
institutional database, children with congenital heart disease who underwent 
tracheostomies had the highest in-hospital mortality when compared to children who 
underwent tracheostomies in association with other underlying illnesses.[6]  A more 
recent single center study by Rosner et al reported survival at 2 years after 
tracheostomy to be just 28% in patients with a history of prior cardiac surgery as 
compared to 75% in patients with no history of cardiac surgery [5].  Tracheostomy after 
cardiac surgery therefore appears to be relatively infrequent but associated with high 
mortality. 
 
Single center reports, though very important additions to the literature, have included a 
relatively small number of subjects, ranging from 4 to 59 cardiac surgical patients who 
underwent tracheostomy.[1-5]  In order to better understand the epidemiology of patients 
who undergo tracheostomy after surgery for congenital heart disease, analysis of a 
larger cohort of patients from multiple centers is needed.  To our knowledge, no such 
4 
 
multi-center study related specifically to patients who undergo tracheostomy after 
surgery for congenital heart disease has been conducted.  We therefore aimed to utilize 
the Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) to 
explore the epidemiology and outcomes of patients who undergo tracheostomy after 
surgery for congenital and/or pediatric heart disease.   
 
Patients and Methods 
Data Source 
As of June 2014, the STS-CHSD contains de-identified data on more than 320000 
surgeries conducted since 2000 at 119 centers in North America. It is estimated that the 
database currently represents greater than 95% of all US centers that perform 
congenital heart surgery and greater than 98% of all congenital and pediatric cardiac 
operations [7]. Preoperative, operative, and outcomes data are collected on all patients 
undergoing pediatric and congenital heart surgery at participating centers. Coding for 
this database is accomplished by clinicians and ancillary support staff using the 
International Pediatric and Congenital Cardiac Code [8,9] and is entered into the 
contemporary version of the STS-CHSD data collection form (DCF).[10]  The Duke 
Clinical Research Institute serves as the data warehouse and analytic center for all STS 
National Databases. Evaluation of data quality includes the intrinsic verification of data, 
along with a formal process of in-person site visits and data audits conducted by a panel 
of independent data quality personnel and pediatric cardiac surgeons at approximately 
10% of participating institutions each year.[7]  Approval for the study was obtained from 
the Duke University Medical Center Institutional Review Board as well as the Access 
and Publications Task Force of the STS Workforce on Research Development and was 
not considered human subjects research in accordance with the Common Rule (45 CFR 
46.102(f)). 
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Study Population 
The STS-CHSD was queried for all index operations between 1/2000 - 6/2014 with the 
complication “postoperative tracheostomy” or “respiratory failure, requiring 
tracheostomy.” Patients who had tracheostomy already in place prior to cardiac surgery 
and patients less than 2.5 kg undergoing isolated closure of patent ductus arteriosus 
were excluded.  
 
Data Collection and Definitions 
All instances of tracheostomy after cardiac surgery coded in the STS CHSD between 
1/2000 - 6/2014 were identified and are reported as cumulative occurrence rate, center-
specific occurrence rate, and annual occurrence rate.  In January 2010, the STS-CHSD 
began analyzing operative mortality based on a definition that includes (1) mortality 
occurring before discharge from the hospital where the index cardiac operation took 
place or any secondary acute care facility, (2) any out-of-hospital deaths occurring within 
30 days of the index cardiac operation, and (3) any deaths occurring in a secondary 
chronic care facility (or rehabilitation facility) within 180 days following the index cardiac 
operation. This definition of operative mortality is particularly relevant to our study 
population, since patients with tracheostomy after cardiac surgery often are transferred 
for ongoing care to either secondary acute care or rehabilitation facilities.[6,11].  We 
therefore explored the occurrence of postoperative tracheostomy across the entire 
period (2000 - 2014), but limited the analyses including preoperative risk factors, 
diagnostic and operative variables, and outcomes data as currently defined in the STS-
CHSD to the time period of 1/2010 - 6/2014.   
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Statistical Analysis 
To determine if there has been any change in the use of tracheostomy over the study 
time period 1/2000 - 6/2014, annual incidences of tracheostomy, defined as the 
occurrence rates of tracheostomy each year (with the 95% Clopper-Pearson confidence 
interval for the proportions), were calculated.   Annual incidence of tracheostomy for 
each year was calculated as follows: number of index operations with a complication of 
tracheostomy divided by the number of index operations performed.  To determine if the 
occurrence rate of tracheostomy differed in relation to center surgical volume during the 
same time period, we calculated the occurrence rate for the following surgical volume 
categories: <150 cases per year, 150-349 cases per year, and >350 cases per year, 
consistent with previous analyses.[12]  Trends in tracheostomy occurrence over time 
and across centers were analyzed using Cochran-Armitage tests.  
 
Descriptive statistics were used for patient characteristics and outcomes of those 
patients reported to have required tracheostomy during 1/2010 - 6/2014.   Absolute 
counts and percentages are used for categorical variables and median and interquartile 
ranges (25th and 75th percentiles) are provided for continuous variables.   Study 
patients who died (i.e. operative mortality) were compared to study patients who 
survived using χ2 tests or Wilcoxon Rank-sum tests as appropriate for individual 
variables.  Patients missing data on operative mortality were not included in this 
analysis.  All analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, 
NC) and R 3.2.1 software (R Foundation for Statistical Computing, Vienna, Austria). A 
probability value of less than 0.05 was considered statistically significant. 
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Results 
From 1/2000 - 6/2014, 211,408 index cardiovascular operations without the presence of 
tracheostomy preoperatively occurred at the 119 centers participating in the STS-CHSD.  
The incidence of tracheostomy over time is illustrated in Figure 1.  The rate of 
tracheostomy increased from 3 of 2625 patients (0.11%; 95% CI’s: 0 - 0.24) in 2000 to a 
peak of 173 of 22798 patients in 2012 (0.76%; 95% CI’s: 0.65-0.88) followed by 150 of 
23390 patients in 2013 (0.64%; 95% CI’s: 0.54 - 0.74).  The overall tracheostomy rate 
for the period 1/2000 - 6/2014 for each center in the context of their average annual 
surgical center volume is provided in Figure 2.  Higher volume centers (i.e. > 350 cases 
per year) had significantly lower rates of tracheostomy.     
 
From 1/2010 to 6/2014, 648 patients within the STS-CHSD underwent postoperative 
tracheostomy.  Patient demographics, anthropometric measurements, and pre-, peri- 
and postoperative characteristics are summarized in Table 1, and the 10 most common 
primary cardiac diagnoses and index cardiac surgical procedures performed are listed in 
Table 2.  Median age was 2.5 months (range: 0 - 79.3 years, interquartile range: 0.4 - 7 
months).  Forty-six patients were adults with congenital or pediatric heart disease, i.e. 
greater than or equal to 18 years of age.  Patients frequently had premature birth, and 
genetic and chromosomal abnormalities were especially prevalent (47.5%).  
Preoperative mechanical ventilation was also very common.  Postoperative 
complications in addition to the need for tracheostomy, were seen nearly all cases 
(96.0%), with the most common being delayed sternal closure, sepsis, cardiac arrest, 
chylothorax, mechanical circulatory support, phrenic or laryngeal nerve injury, and 
neurologic deficit persistent at discharge.  The percentages of operative mortality and 
postoperative complications in patients with tracheostomies are illustrated in Figure 3 
along with the percentages of postoperative complications in the 98298 patients in the 
8 
 
STS-CHSD database who did not require tracheostomy during the same time period.  
There was wide range of diagnoses and procedures in this cohort.  Hypoplastic left heart 
syndrome and other single ventricle lesions comprised the largest portion of the cohort 
(16.6%) and, accordingly, the Norwood procedure was the most common index cardiac 
surgical procedure performed. 
  
Operative mortality for the 606 patients for which these data were available was 25.2% 
(n=153).  Outcome data including location where death occurred are summarized in 
Figure 4.  The annual mortality rate was relatively consistent over time (2010-2013), 
ranging from 24.5% - 27.5%.  Patients with hypoplastic left heart syndrome had 
significantly higher mortality (25 of 57 patients, 44%) as compared to the rest of the 
cohort (p=0.0007), while patients with ventricular septal defects-type 2 had significantly 
lower mortality (2 of 28 patients, 7%) than the rest of the cohort (p=0.024).  No other 
underlying diagnoses were associated with higher or lower mortality in relation to the 
rest of the patients, including other single ventricle lesions (13 of 49 patients, 26.5%, 
p=0.829).  Patient characteristics of those who survived are compared to patients who 
died in Table 3.  In regards to pre- or perioperative characteristics, patients who died 
were more likely to require preoperative mechanical ventilator support.  Otherwise, there 
were no other differences observed in preoperative characteristics including STAT 
mortality category of the index procedure.   Postoperatively however, several major 
complications occurred more frequently in those patients with tracheostomy who 
ultimately died as compared to those who survived, including mechanical circulatory 
support, cardiac arrest, sepsis, and chylothorax. Patients who died were also likely to 
require additional cardiovascular procedures within their admission following their index 
cardiovascular procedure (Table 4).  On the other hand, the presence of recurrent 
9 
 
laryngeal nerve injury was significantly more common in survivors, and a similar trend 
was observed with respect to phrenic nerve injury. 
 
Comment 
 
This study represents the largest cohort to date of patients who received tracheostomy 
following surgery for congenital heart disease.  Foremost, the incidence of tracheostomy 
following cardiac surgery has steadily increased over the past decade.  An earlier multi-
center report from the Kids’ Inpatient Database similarly reported a significant increase 
from 1997 to 2006 in the number of patients with congenital heart disease who 
underwent tracheostomy as a proportion of all children undergoing tracheostomy.[6]  
These trends underscore the importance of the descriptive data from STS-CHSD 
provided in this report, which should provide clinicians with a better understanding of 
contemporary practice in regards to this complex patient population.      
 
It can also be surmised from the data in this report that patients who require 
tracheostomy following surgery for congenital heart disease, for the most part, are high-
acuity patients with complicated postoperative courses, as evidenced by the 
considerable prevalence of postoperative delayed sternal closure, cardiac arrest, 
mechanical circulatory support, and sepsis.  Not surprisingly, in-hospital mortality was 
high, especially in patients who experienced the aforementioned postoperative 
morbidities.  In comparison, in a retrospective analysis of 917 children with any 
diagnoses undergoing tracheostomy from 36 children’s hospitals, Berry and colleagues 
reported an in-hospital mortality of only 7.7%.[13]  Additionally, in-hospital mortality of 
our cohort was also higher than reported in the majority of the available single center 
studies.[1,3-5]  This finding possibly reflects the inclusion of deaths that occur in patients 
discharged to chronic care or rehabilitation facilities.  Indeed, in the study by Berry and 
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colleagues, 19% of all patients who had tracheostomies had been discharged to a post-
acute care facility after at least one admission and 9.6% had only been discharged to 
such a facility.[13]  The in-hospital mortality rate of 25% in this report is therefore likely 
more indicative of the proportion of deaths that are suffered by these patients prior to 
being discharged home.  
 
In most cases, one of the goals of tracheostomy is to facilitate the safe discharge of 
patients with airway abnormalities or the persistent need for mechanical ventilation to 
home.  Examining our data from this standpoint, this goal was not achieved in 25% of all 
cases and nearly half (44%) of all patients with hypoplastic left heart syndrome.  In 
contrast, in the Single Ventricle Reconstruction Trial, a prospective trial of 549 infants 
undergoing stage I palliation for hypoplastic left heart syndrome, in-hospital mortality 
was 16%.[14]  Follow-up data on the 75% of our study patients who were ultimately 
discharged to home is not available in the STS-CHSD.  Available long-term follow-up 
data from other studies, however, are not encouraging, especially in regards to patients 
with hypoplastic left heart syndrome and those requiring long-term ventilation.   In a 
study of 35 children with congenital heart disease enrolled in a home mechanical 
ventilation program, 5 year survival in the entire cohort was 68% but only 12% in 
patients with Risk Adjusted Classification for Congenital Heart Surgery score (RACHS-1) 
≥ 4 (only 1 of 9 patients survived).[15,16]  Moreover, only 1 of 6 patients with single 
ventricle anatomy completed the three stages of surgical palliation - a child with a single 
functional left ventricle.  Cotts and colleagues similarly reported only 1 of 13 patients with 
single ventricle anatomy who required long-term ventilation survived through the three 
surgical stages.[4]  Lastly, in the aforementioned study by Rosner et al, 17 of 18 patients 
with tracheostomy in association with cardiac surgery were discharged to home with the 
need for long-term ventilation.  Two year survival in this study was only 28%, and all of 
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the 4 patients with single ventricle anatomy died prior to the second stage of their 
palliation.[5]   Based on these data along with the data in our study, the need for 
tracheostomy and long-term ventilation likely signifies the presence of considerable 
concomitant lower airway or lung pathology in these fragile patients, increasing their risk 
for poor outcomes.   Both short and long-term prognoses in patients with complex 
cardiac lesions and single ventricle anatomy who require tracheostomy and long-term 
ventilation could therefore be considered guarded at best, and this information should be 
made clear to the families of these patients prior to undertaking the procedure.   More 
long-term follow-up data from this population are sorely needed. 
 
On the other hand, our data suggest that prognoses in certain sub-groups may be more 
optimistic.  For example, all but 2 patients in our cohort with ventricular septal defect 
type 2 as their primary diagnosis survived.  Edwards and colleagues reported a 5 year 
survival rate of 90% in patients with RACHS-1 score of ≤ 3 who require tracheostomy 
and long-term mechanical ventilation.[15]   We speculate that a relatively lower 
cumulative burden of disease is likely present in these lower complexity patients, giving 
them this apparent survival advantage.  Patients in our report with recurrent laryngeal 
nerve palsy also seemed to have lower in-hospital mortality.  Berry and colleagues 
reported a similar finding: in 883 patients with congenital heart disease who underwent 
tracheostomy in 2006, in-hospital mortality in patients with an upper airway anomaly was 
7.3% as compared to 27.2% in patients without an upper airway anomaly.[6]  Data from 
the report from Cotts et al also corroborates these findings: all six patients with single 
ventricle anatomy and isolated vocal cord paralysis who required tracheostomy for 
airway protection (i.e. no need for long-term ventilation) survived through all three stages 
of their surgical palliation.[4]  For many of the children in these subgroups, tracheostomy 
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is likely a valuable and potentially life-sustaining therapy without which hospital 
discharge and long-term survival could not occur. 
 
This study has some limitations, most importantly of which is the inability to assess 
intermediate and long-term outcomes. In the current iteration of the STS-CHSD, data 
can only support inferences concerning mortality status and peri- and postoperative 
complications. In addition, we did not perform a multivariable analysis due to concerns of 
confounders not accounted for within the available dataset.  It is also difficult, based on 
the STS-CHSD data, to make definitive conclusions regarding relationship between 
occurrence rate of tracheostomy and individual centers.   Though center-to-center 
variations in indication for tracheostomy, timing of tracheostomy, and post-tracheostomy 
care could potentially influence outcomes, these data are not explicitly reported to the 
STS-CHSD database. Further, the number of centers participating in the STS-CHSD 
increased considerably during the period of study, therefore confounding the center 
experience analysis. The number of cases per center is influenced not only by the 
pattern of practice but also by the longevity of database participation.    
 
In conclusion, the incidence of tracheostomy as a complication of surgery for congenital 
heart disease has consistently increased since 2000.  Tracheostomy is being utilized in 
patients at all levels of surgical complexity and most prevalent in patients with 
complicated postoperative courses.  Use of tracheostomy may not be of equivalent 
benefit in all types of patients, and warrants careful consideration in certain patient 
populations such as infants with hypoplastic left heart syndrome likely to require chronic 
mechanical ventilation.  Long-term follow-up data in a large cohort of these patients are 
therefore needed to evaluate further the role of tracheostomy following cardiovascular 
surgery. 
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Tables 
 
Table 1.  Characteristics of Patients Requiring Tracheostomy after Surgery for 
Congenital Heart Disease, 1/2010 – 6/2014 (N=648) 
Preoperative Data  
Age at Surgery (months) 2.5 (0.4, 7) 
Gender 
 Male 
 Female 
 Ambiguous 
 
348 (53.7%) 
298 (46%) 
1 (0.2%) 
Weight at Surgery (kg) 4.0 (3.0, 6.5) 
Prematurity (<37 weeks completed gestation) 165 (25.5%) 
Preoperative Mechanical Ventilatory Support 275 (42.4%) 
Neurological Deficit 53 (8.2%) 
Down Syndrome (Trisomy 21) 56 (8.6%) 
DiGeorge Syndrome (22q11 Deletion) 51 (7.9%) 
Any other genetic / chromosomal abnormality 201 (31.0%) 
Peri- and Postoperative Data  
STAT Mortality Category 
 1 
 2 
 3 
 4 
 5 
 Uncategorized 
68 (10.5%) 
118 (18.2%) 
90 (13.9%) 
271 (41.8%) 
82 (12.7%) 
19 (2.9%) 
CPB Time (minutes) 137.0 (91.0, 189.0) 
Circulatory Arrest Used 130 (20.1%) 
Delayed sternal closure 178 (27.5%) 
Mechanical circulatory support 87 (13.4%) 
Cardiac arrest 131 (20.2%) 
Chylothorax 102 (15.7%) 
Recurrent laryngeal nerve injury 60 (9.3%) 
Phrenic nerve injury / paralyzed diaphragm 62 (9.6%) 
Neurological deficit persisting at hospital discharge 51 (7.9%) 
Septicemia 143 (22.1%) 
Mediastinitis 17 (2.6%) 
Additional cardiovascular procedures prior to discharge 293 (45.2%) 
Continuous data represented as median (25th percentile, 75th percentile) and categorical data are 
represented as absolute counts (percentages) 
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Table 2. Most Common Primary Diagnoses and Procedures for Patients Requiring 
Tracheostomy after Surgery for Congenital Heart Disease, 1/2010 – 6/2014 
      n a  Mortality b  
Primary Diagnosis   
Hypoplastic left heart syndrome  62 (9.6%) 25 (44%) 
Other Single Ventricle Lesions 50 (7.7%) 13 (26%) 
Atrioventricular septal defect, complete 44 (6.8%) 8 (19%) 
Ventricular septal defect, Type 2  29 (4.5%) 2 (7%) 
Patent ductus arteriosus 25 (3.9%) 6 (24%) 
Pulmonary atresia, ventricular septal defect 20 (3.1%) 6 (32%) 
Tetralogy of Fallot, absent pulmonary valve 20 (3.1%) 6 (33%) 
Truncus arteriosus 19 (2.9%) 3 (17%) 
Coarctation of aorta 17 (2.6%) 1 (7%) 
Tetralogy of Fallot 14 (2.2%) 2 (14%) 
Primary Procedure   
Norwood procedure 47 (7.3%) 15 (33%) 
Pulmonary artery banding 33 (5.1%) 7 (23%) 
Atrial septal defect creation / enlargement 30 (4.6%) 5 (17%) 
Ventricular septal defect repair, patch  30 (4.6%) 9 (32%) 
Atrioventricular septal defect repair, complete 29 (4.5%) 4 (14%) 
Patent ductus arteriosus closure, surgical 25 (3.9%) 5 (21%) 
Aortic arch repair 21 (3.2%) 3 (16%) 
Transplant, Heart 20 (3.1%) 4 (22%) 
Modified Blalock-Taussig Shunt 19 (2.9%) 4 (24%) 
Pulmonary atresia, reconstruction  17 (2.6%) 3 (18%) 
a Data represented as absolute counts with percentages of total patients in study, N=648 
b Data represented as absolute counts with percentages of patients with mortality data available, 
N=606 
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Table 3.  Comparison of Preoperative Characteristics between Patients Who Died and 
Survived after Tracheostomy following Surgery for Congenital Heart Disease 
Preoperative Data Survived 
N=453 
Died 
N=153 
p-value
Age at Surgery (months) 2.6 (0.5, 7.0) 2.0 (0.3, 7.4) 0.2370 
Gender 
 Male 
 Female 
 Ambiguous 
 
242 (53.4%) 
210 (46.4%) 
0 (0%) 
 
85 (55.6%) 
67 (43.8%) 
1 (0.7%) 
 
0.2006 
Weight at Surgery (kg) 4.0 (3.1, 6.8) 3.9 (3.0, 6.1) 0.3426 
Prematurity (<37 weeks completed gestation) 120 (26.5%) 33 (21.6%) 0.3013 
Mechanical Ventilator Supporta 183 (40.4%) 76 (49.7%) 0.0247 
Neurological Deficit 40 (8.8%) 11 (7.2%) 0.5730 
Down Syndrome (Trisomy 21) 41 (9.1%) 11 (7.2%) 0.4669 
DiGeorge Syndrome (22q11 Deletion) 36 (7.9%) 8 (5.2%) 0.2563 
Any other genetic / chromosomal abnormality 140 (30.9%) 50 (32.7%) 0.7077 
STAT Mortality Categoryb 
 1 
 2 
 3 
 4 
 5 
 Unclassified 
 
53 (11.7%) 
81 (17.9%) 
68 (15%) 
188 (41.5%) 
54 (11.9%) 
9 (2.0%) 
 
9 (5.9%) 
29 (19%) 
20 (13.1%) 
60 (39.2%) 
27 (17.6%) 
8 (5.2%) 
 
0.1314 
Continuous data represented as median (25th percentile, 75th percentile) and categorical data are 
represented as absolute counts (percentages) 
a Mechanical ventilator support is coded as a preoperative factor when a patient is “supported 
with mechanical ventilation to treat cardiorespiratory failure during the hospitalization of his or her 
operation and prior to operating room entry date and time 
b STAT: Society of Thoracic Surgeons-European Association of Cardio-Thoracic Surgery 
Congenital Heart Surgery Mortality Categories  
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Table 4.  Comparison of Peri- and Postoperative Characteristics between Patients Who 
Died and Survived after Tracheostomy following Surgery for Congenital Heart Disease 
Peri- and Postoperative Data 
Survived 
N=453 
Died 
N=153 
p-value
CPB Time (minutes) 136 (89,193) 153 (94,195) 0.1913 
Circulatory Arrest Used 85 (18.8%) 34 (22.2%) 0.3522 
Norwood Procedure 31 (6.8%) 15 (9.8%) 0.2323 
Delayed sternal closure 107 (23.6%) 61 (39.9%) 0.0001 
Mechanical circulatory support 49 (10.8%) 35 (22.9%) 0.0002 
Cardiac arrest 71 (15.7%) 55 (35.9%) <.0001 
Chylothorax 55 (12.1%) 40 (26.1%) <.0001 
Recurrent laryngeal nerve injury 48 (10.6%) 8 (5.2%) 0.0477 
Phrenic nerve injury / paralyzed diaphragm 51 (11.3%) 9 (5.9%) 0.0544 
Neurological deficit at discharge 33 (7.3%) 17 (11.1%) 0.1373 
Septicemia 83 (18.3%) 51 (33.3%) 0.0001 
Wound infection 12 (2.6%) 5 (3.3%) 0.6888 
Mediastinitis 14 (3.1%) 3 (2.0%) 0.4647 
Additional cardiovascular procedures 189 (41.7%) 89 (58.2%) 0.0004 
Data are represented as absolute counts (percentages).   
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Figure Legends 
Figure 1. Incidence of tracheostomy over time.  The incidence of tracheostomy 
increased over time, from 0.11% in 2000 to a peak of 0.76% in 2012.  Note that 2014 
represents partial year data (January - June). 
 
Figure 2. Center level occurrence rate of tracheostomy graphed by average annual 
surgical volume, 1/2000 – 6/2014.  Higher volume centers had significantly lower rates of 
tracheostomy utilization (Cochrane-Armitage Test for trend: Z=7.31, p<0.0001). 
 
Figure 3.  Operative mortality and complications in patients who required tracheostomy 
after cardiac surgery (gray bars) and patients who did not (black bars), 2010-2014.  
 
Figure 4.  Outcomes for patients who underwent tracheostomy between 2010-2014 and 
had mortality data available (N=606).  Of these patients, 453 survived (white), 134 died 
prior to hospital discharge (dotted), 17 died at outside facilities prior to discharge home, 
and 2 patients died outside of a medical facility but within 30 days of surgery (black). 
 




